TNFSF14 and colitis: Neutralization or genetic ablation of LIGHT ameliorates DSS colitis. LIGHT-/- mice showed dramatically less intestinal inflammation than WT. Anti-LIGHT mAb treatment in WT mice reduced disease severity.